Heme Iron.

Heme iron is shielded from phytate and polyphenols by its porphyrin ring, but calcium still reduces its absorption. That makes calcium the interaction to time around for a heme source.

Hephaestin and ceruloplasmin are copper enzymes that oxidise ferrous iron so it can be loaded onto transferrin after leaving the enterocyte. Without copper, absorbed iron is not moved into circulation efficiently.

Flavin-dependent reductases release iron from ferritin stores and support its use in red cell formation. Riboflavin status therefore changes how efficiently an iron dose is utilised.

Vitamin A status affects the release of iron from stores and its incorporation into developing red cells. Iron intake alone responds poorly when vitamin A status is low.

Iron supplies the heme while folate supplies the one-carbon units for DNA synthesis in dividing erythroid precursors. Both are needed at once for normal red cell output.

B12 works with folate in the thymidylate step required for erythroid cell division, while iron builds the heme those cells fill with. The two requirements are simultaneous, not interchangeable.

Delta-aminolevulinate synthase uses pyridoxal 5-phosphate to start the porphyrin ring that iron is later inserted into. B6 builds the ring, iron completes it.

Zinc and iron interfere with each other when given together in large doses without food, sharing uptake and transport routes. Separating them or taking them with a meal reduces the effect.

Ascorbate strongly enhances non-heme iron absorption by reducing ferric to ferrous iron, but heme iron enters intact through its own carrier and gains little from it. The honest read is that vitamin C is a much smaller lever for a heme source than for a mineral salt.

Tea polyphenols chelate free ferric iron and sharply reduce non-heme absorption, while heme iron is protected inside its porphyrin ring. This is the main practical advantage of a heme source in a polyphenol-rich diet.

Heme synthesis opens with glycine condensing with succinyl-CoA to form aminolevulinic acid, the committed step catalysed by ALA synthase. Glycine is therefore a direct structural precursor of the porphyrin ring that carries the iron. This describes how the body builds heme, not an absorption effect from taking the two together.

Heme and non-heme iron enter the enterocyte by different routes, so supplying both presents iron to two independent uptake systems rather than saturating one. An in vitro study of combined heme and non-heme supplementation reported greater uptake markers than either source alone in that model. Cell-model uptake is a marker, not a human outcome, and total iron load still needs to stay within sensible limits.

Bisglycinate is a chelated non-heme form that resists the phytate and polyphenol inhibition that affects ferrous salts, and heme iron uses a separate route again. Formulas that carry both are covering two pathways. Both still funnel into the same body iron pool, so the doses are additive and should be counted as one total.

Lactoferrin binds ferric iron tightly and is taken up by its own receptor-mediated route, distinct from both heme and ionic non-heme uptake. Products combining it with heme iron are presenting iron in a third chemical context rather than adding to one route. Human comparisons of the combination are limited.

Calcium taken in the same meal reduces the absorption of iron, and unusually among inhibitors it acts on heme iron as well as non-heme iron. A calcium supplement and a heme iron dose are therefore worth separating by a couple of hours. The effect is on a single meal rather than on long-term status when total intakes are adequate.

Tannins chelate non-heme iron in the gut lumen and sharply reduce its uptake, which is the well described tea and coffee interaction. Heme iron is largely shielded from this because its iron stays inside the porphyrin ring until it is already inside the enterocyte. The contrast is the main practical argument put forward for heme forms.

Phytate binds non-heme iron and blocks its absorption, and phytase hydrolyses phytate to relieve that block. Heme iron is not meaningfully affected by phytate, so adding phytase changes the fate of the non-heme fraction of a meal rather than the heme fraction. In a mixed formula the enzyme is working on the other iron source.

Ferric iron needs an acidic stomach to be solubilised and reduced before uptake, which is why low gastric acidity blunts non-heme absorption. Heme iron is less dependent on that step because the metal is already coordinated inside the porphyrin. Betaine hydrochloride is therefore aimed at the non-heme half of a mixed formula.

A large viscous fibre dose in the same meal can lower mineral uptake by trapping ions in the gel phase and speeding transit past the absorptive window. How much this touches heme iron specifically is not well quantified. Spacing a fibre serving from an iron dose removes the uncertainty.

Manganese and non-heme ferrous iron both cross the enterocyte brush border on DMT1 and compete for it. Heme iron bypasses DMT1 at the apical membrane, so the competition applies to the non-heme fraction of a meal. Once heme is degraded inside the cell, its released iron joins the same intracellular pool.

Cysteine-containing peptides released during meat digestion keep iron in the reduced ferrous state and improve non-heme uptake, the effect known as the meat factor. Since heme iron supplements are themselves meat-derived hydrolysates, that peptide context travels with them. The enhancement described in the literature is for the non-heme iron in the same meal.